Pay in 4 interest-free payments of $24.00 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
and FGFR4 with IC50=60 nM
may improve hypertension-associated vascular endothelial dysfunction
PubMed Central PMCID: PMC6762047
InChi: InChI=1S/C14H17N5O2S/c20-13(19-6-2-1-3-7-19)9-15-14(21)16-10-4-5-11-12(8-10)22-18-17-11/h4-5
WO2007013673A1
Telbivudine Catalog No.:M9354-10 and FGFR4 with IC50=60 nMTelbivudine is an antiviral drug used in the treatment of hepatitis B infection. It is marketed by Swiss pharmaceutical company Novartis under the trade names Sebivo (Europe) and Tyzeka (United States). Clinical trials have shown it to be significantly more effective than lamivudine or adefovir, and less likely to cause resistance. Telbivudine is a synthetic thymidine nucleoside analogue; it is the L isomer of thymidine. Product information CAS
US$ 200.00
US$ 125.00
US$ 490.00
US$ 282.50
US$ 1152.50
US$ 682.50
US$ 1530.00
US$ 1725.00
US$ 195.00